DXCM Q2 EPS $0.70 vs. est. $0.61; Q2 revs rose 13% Y/y to $1.31B vs. est. $1.29B; raises midpoint of 2026 revenue guidance to $5.18-$5.25B,
DXCM Q2 EPS $0.70 vs. est. $0.61; Q2 revs rose 13% Y/y to $1.31B vs. est. $1.29B; raises midpoint of 2026 revenue guidance to $5.18-$5.25B, up 11-13% and said expects 2026 non-GAAP gross profit margin of about 64%; Q2 said international revs grew 19% Y/y on a reported basis and 16% on an organic basis; shares +3%
DXCM Q2 EPS $0.70 vs. est. $0.61; Q2 revs rose 13% Y/y to $1.31B vs. est. $1.29B; raises midpoint of 2026 revenue guidance to $5.18-$5.25B, up 11-13% and said expects 2026 non-GAAP gross profit margin of about 64%; Q2 said international revs grew 19% Y/y on a reported basis and 16% on an organic basis; shares +3%